Web
Analytics

FDA okays Israeli drug for coronavirus treatment trials

13

This is what Israel is doing. The gift of the Jews.

This is what Israel’s enemies are doing:

FDA okays Israeli drug for coronavirus treatment trials

i24NEWS, March 30, 2020:

Researchers hope drug can treat a condition that accounts for some 50% of coronavirus deaths

NeuroRx, a US-Israeli pharmaceutical company, and Relief Therapeutics, a Swiss drug development company, announced Sunday they received a go-ahead from the Food and Drug Administration for phase two trials for a drug that could take on a deadly condition associated with COVID-19.

The two companies announced Sunday that the FDA issued a “study may proceed” letter — which does not amount to a full-fledged drug approval — for the substance to be tried on COVID-19 patients.

The drug in question, Aviptadil, is a synthetic form of a neuropeptide hormone that works to enable communications between neurons in the human nerve system.

The researchers are hoping that Aviptadil will be able to take on the so-called Acute Respiratory Distress Syndrome (ARDS) — a condition that killed about 50% of COVID-19 fatalities.

ARDS is a respiratory system failure induced by a rapid and severe lung inflammation, with breath shortness — a symptom COVID-19 is widely associated with — among its key signs.

It effectively brings to a halt the oxygen and carbon dioxide exchange in the patient’s lungs, necessitating the use of an artificial lung ventilation machine.

Have a tip we should know? Your anonymity is NEVER compromised. Email tips@thegellerreport.com

The Truth Must be Told

Your contribution supports independent journalism

Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.

Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.

Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.

Please contribute here.

or

Make a monthly commitment to support The Geller Report – choose the option that suits you best.

Pin It on Pinterest